AFT Pharmaceuticals Ltd (AFT)

Currency in NZD
3.30
+0.14(+4.43%)
Closed·
Unusual trading volume
AFT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.163.30
52 wk Range
2.373.36
Key Statistics
Bid/Ask
3.25 / 3.30
Prev. Close
3.16
Open
3.17
Day's Range
3.16-3.3
52 wk Range
2.37-3.36
Volume
280.2K
Average Volume (3m)
20.22K
1-Year Change
0.31%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
AFT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.80
Upside
+15.15%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

AFT Pharmaceuticals Ltd News & Analysis

Show more

AFT Pharmaceuticals Ltd Company Profile

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital. It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Employees
119

Compare AFT to Peers and Sector

Metrics to compare
AFT
Peers
Sector
Relationship
P/E Ratio
27.7x16.7x−0.7x
PEG Ratio
−1.070.500.00
Price/Book
3.4x1.7x2.6x
Price / LTM Sales
1.6x1.6x3.4x
Upside (Analyst Target)
18.8%25.8%37.6%
Fair Value Upside
Unlock20.8%5.3%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.80
(+15.15% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.11%
Dividend Yield
0.62%
Industry Median 3.93%
Annualised payout
0.02
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 22, 2025
EPS / Forecast
0.14 / --
Revenue / Forecast
121.31M / --
EPS Revisions
Last 90 days

AFT Income Statement

FAQ

What Stock Exchange Does AFT Pharmaceuticals Ltd Trade On?

AFT Pharmaceuticals Ltd is listed and trades on the New Zealand Exchange stock exchange.

What Is the Stock Symbol for AFT Pharmaceuticals Ltd?

The stock symbol for AFT Pharmaceuticals Ltd is "AFT."

What Is the AFT Pharmaceuticals Ltd Market Cap?

As of today, AFT Pharmaceuticals Ltd market cap is 336.36M.

What Is AFT Pharmaceuticals Ltd's Earnings Per Share (TTM)?

The AFT Pharmaceuticals Ltd EPS (TTM) is 0.11.

From a Technical Analysis Perspective, Is AFT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has AFT Pharmaceuticals Ltd Stock Split?

AFT Pharmaceuticals Ltd has split 0 times.

How Many Employees Does AFT Pharmaceuticals Ltd Have?

AFT Pharmaceuticals Ltd has 119 employees.

What is the current trading status of AFT Pharmaceuticals Ltd (AFT)?

As of 17 Oct 2025, AFT Pharmaceuticals Ltd (AFT) is trading at a price of 3.30, with a previous close of 3.16. The stock has fluctuated within a day range of 3.16 to 3.30, while its 52-week range spans from 2.37 to 3.36.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.